Hollande, C et al. reported that the administration of a novel antidiabetic drug, sitagliptin, was associated with enlarged eosinophils migration into solid tumors and that IL-33 was necessary for anti-tumor responses mediated by eosinophils [12]. The gene discussed is IL33; the disease is neoplasm.